Your browser doesn't support javascript.
loading
Open-label Phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L.
Tarakanovskaya, Marina G; Chinburen, Jigjidsuren; Batchuluun, Purev; Munkhzaya, Chogsom; Purevsuren, Genden; Dandii, Dorjiin; Hulan, Tsogkhuu; Oyungerel, Dandii; Kutsyna, Galyna A; Reid, Alan A; Borisova, Vika; Bain, Allen I; Jirathitikal, Vichai; Bourinbaiar, Aldar S.
Afiliação
  • Tarakanovskaya MG; Ekomed LLC.
  • Chinburen J; National Cancer Center.
  • Batchuluun P; National Cancer Center.
  • Munkhzaya C; National Cancer Center.
  • Purevsuren G; National Cancer Center.
  • Dandii D; Monserum LLC.
  • Hulan T; Monserum LLC.
  • Oyungerel D; National Center for Public Health, Ulaanbaatar, Mongolia.
  • Kutsyna GA; Department of Infectious Diseases, Luhansk State Medical University, Luhansk, Ukraine.
  • Reid AA; Immunitor China Ltd, Beijing, People's Republic of China.
  • Borisova V; Immunitor China Ltd, Beijing, People's Republic of China.
  • Bain AI; Immunitor Inc, Vancouver, BC, Canada.
  • Jirathitikal V; Immunitor Inc, Vancouver, BC, Canada.
  • Bourinbaiar AS; Immunitor China Ltd, Beijing, People's Republic of China.
J Hepatocell Carcinoma ; 4: 59-69, 2017.
Article em En | MEDLINE | ID: mdl-28443252
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2017 Tipo de documento: Article